skip to Main Content

ESG News Review 1 — 7 March 2014

  • 10 March 2014

Ecolab appeared among the most praised companies last week after it received a 2014 Climate Leadership Award from the U.S. Environmental Protection Agency (EPA) for achieving aggressive greenhouse gas emissions reduction goals. Pacific Gas and Electric Co. (PG&E) announced they…


L’indice 60 atteint +25% depuis janvier

  • 26 November 2013

Nestlé a tiré son épingle du jeu dans l’actualité Environnement, Social, Gouvernance (ESG) du mois d’octobre, grà¢ce notamment au 2013 Creating Shared Value Forum, qui a mis en évidence les efforts de la société en matière de développement rural en…


ESG News Review 12 — 18 October 2013

  • 21 October 2013

Dell Inc. was among the most praised companies last week for joining forces with Members of Women’s Business Enterprise National Council (WBENC) and WEConnect to support women entrepreneurs. Dell Inc. also launched 2020 Legacy of Good Plan initiative for sustainable…


Pharma Reputations: Managing Perceptions

  • 14 August 2012

Geneva-based Covalence, a company that markets the information system, EthicalQuote, has observed that pharma is not keeping pace with other industries in terms of the overall balance of global good and bad news coverage in four broad ethical areas: labour…


Index sur l’Accès aux Médicaments : Publication des résultats

  • 25 June 2008

L'accès aux médicaments dans les pays en voie de développement est un des grands défis posé actuellement aux entreprises pharmaceutiques. Conscients du problème, Ethos et plusieurs investisseurs institutionnels soutiennent le projet « Index sur l'Accès aux Médicaments ». Cette initiative…


The Burden of Innovation – Covalence Pharmaceutical Industry Report 2007

  • 29 August 2007

Pharmaceutical companies carry increasing ethical risks related to innovation, states a report released on 29 August 2007 by Geneva-based ethical reputation research firm Covalence, Covalence Pharmaceutical Industry Report 2007. These innovation-related risks deal with intellectual property rights, drug pricing, clinical…


Big Pharma’s new Africa plan

  • 5 July 2007

Unless delegates to a high-profile summit on diabetes in Kenya last week knew it had been paid for by the world's biggest maker of insulin, they would have been none the wiser when they left. The conference, in the lush…


The Ethically Challenged: How Pharma Fares

  • 31 May 2007

In these ethically challenging times, which drugmaker has its act together? Covalence, a research group based in Geneva that tracks ethical reputations, recently released its quarterly update in which various industrial sectors were examined. The firm compiles its rankings and…

Back To Top